Compare Abbott Laboratories (ABT) vs Five Below Inc (FIVE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Five Below Inc — how do they compare? Abbott Laboratories trades at $95.7 (market cap $166.94B), while Five Below Inc trades at $178.13 (market cap $9.75B). The key difference: Abbott Laboratories is far larger — about 17.1× Five Below Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| ABT | FIVE | |
|---|---|---|
Market Cap | $166.94B | $9.75B |
Sector | Health | Consumer Staples |
52-Week High | $136.62 | $247.71 |
52-Week Low | $82.57 | $128.78 |
Enterprise Value | $193.69B | $10.63B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Five Below (FIVE) trades at $176.25, down 3.39% with a bearish technical signal despite strong earnings beats. The company shows solid revenue growth from $3.88B in 2025 to projected $5.1B in 2026, with net income margin improving to 8.67%. Recent news highlights digital marketing success and leadership appointments driving customer engagement. Technical indicators show oversold conditions with RSI at 24.82, while support levels begin at $174.
Analyst consensus remains strongly bullish with 58% buy ratings and $253 price target, representing 44% upside. Key risks include execution of expansion plans and consumer spending sensitivity. The combination of strong fundamentals, positive analyst sentiment, and current technical oversold conditions presents a compelling opportunity for growth investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →
